爱尔眼科(300015)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

300015 爱尔眼科

已收盘 01-30 15:00:00

{"stockData":{"symbol":"300015","market":"SZ","secType":"STK","nameCN":"爱尔眼科","latestPrice":11.07,"timestamp":1769756595000,"preClose":11.41,"halted":0,"volume":123091873,"delay":0,"changeRate":-0.0298,"floatShares":7955000000,"shares":9325000000,"eps":0.3452,"marketStatus":"已收盘","change":-0.34,"latestTime":"01-30 15:00:00","open":11.32,"high":11.39,"low":11.02,"amount":1376000000,"amplitude":0.0324,"askPrice":11.08,"askSize":1275,"bidPrice":11.07,"bidSize":2300,"shortable":0,"etf":0,"ttmEps":0.3452,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1769995800000},"marketStatusCode":5,"adr":0,"adjPreClose":11.41,"symbolType":"stock","openAndCloseTimeList":[[1769736600000,1769743800000],[1769749200000,1769756400000]],"highLimit":12.55,"lowLimit":10.27,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":9325396670,"isCdr":false,"pbRate":4.74,"roa":"--","peRate":32.068366,"roe":"14.32%","epsLYR":0.3847,"committee":0.534817,"marketValue":103232000000,"turnoverRate":0.0155,"status":1,"floatMarketCap":88066000000},"requestUrl":"/m/hq/s/300015","defaultTab":"news","newsList":[{"id":"2606479432","title":"浦银国际证券：首次覆盖爱尔眼科给予买入评级，目标价14.0元","url":"https://stock-news.laohu8.com/highlight/detail?id=2606479432","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606479432?lang=zh_cn&edition=full","pubTime":"2026-01-28 17:41","pubTimestamp":1769593296,"startTime":"0","endTime":"0","summary":"浦银国际证券有限公司胡泽宇,阳景近期对爱尔眼科进行研究并发布了研究报告《全球眼科龙头优势持续强化》，首次覆盖爱尔眼科给予买入评级，目标价14.0元。　　爱尔眼科　　我们首次覆盖爱尔眼科给予“买入”评级和医疗服务行业首选推荐，目标价为人民币14.0元。截至1H25末，公司境内医院355家，门诊部240家。最新盈利预测明细如下：该股最近90天内共有6家机构给出评级，买入评级4家，增持评级2家；过去90天内机构目标均价为15.21。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012800030690.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161027","300015"],"gpt_icon":0},{"id":"2606215614","title":"爱尔眼科：公司目前全部人工成本约占收入的三成","url":"https://stock-news.laohu8.com/highlight/detail?id=2606215614","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606215614?lang=zh_cn&edition=full","pubTime":"2026-01-26 17:27","pubTimestamp":1769419632,"startTime":"0","endTime":"0","summary":"证券之星消息，爱尔眼科(300015)01月26日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘你好，请问爱尔眼科人工成本占营业收入比重为多少，人工成本高的问题怎么解决？谢谢爱尔眼科回复：谢谢您的关注！每个细分行业的运行模式不同，人工成本占比也不同，因此不能简单类比。公司目前全部人工成本约占收入的三成，处于相对合理的水平。公司以患者为中心，不断提高技术服务能力，同时全面推进“智慧眼科医院”建设，持续提高工作效率。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012600023002.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","LU1146622755.USD","BK0113","LU1242518857.USD","BK0012","300015","BK0200","BK0188","BK0077","LU0979878070.USD","LU1242518931.SGD","BK0236","BK0096","BK0196","BK0114","LU1820825898.SGD"],"gpt_icon":0},{"id":"2606633182","title":"股市必读：爱尔眼科（300015）1月23日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2606633182","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606633182?lang=zh_cn&edition=full","pubTime":"2026-01-26 01:48","pubTimestamp":1769363293,"startTime":"0","endTime":"0","summary":"截至2026年1月23日收盘，爱尔眼科报收于11.3元，上涨1.07%，换手率0.96%，成交量76.13万手，成交额8.6亿元。整体来看，中国眼科医疗服务市场仍处于持续发展阶段，长期空间广阔。商业健康保险作为医保的重要补充，正逐步受到市场和患者关注。近年来，多次通过高管增持、股份回购、加大现金分红等措施加强市值管理，同时持续加强与市场的沟通，切实维护全体股东的长远利益。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012600000780.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300015","LU1242518857.USD","LU1820825898.SGD","LU1242518931.SGD","BK0236","LU0979878070.USD","BK0113","BK0077","BK0012","BK0188","BK0096","BK0200","LU1146622755.USD","BK0196","BK0028","BK0114"],"gpt_icon":0},{"id":"2605342495","title":"爱尔眼科：持续建设数智眼科，积极推进“1+8+N”的战略","url":"https://stock-news.laohu8.com/highlight/detail?id=2605342495","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605342495?lang=zh_cn&edition=full","pubTime":"2026-01-23 15:21","pubTimestamp":1769152877,"startTime":"0","endTime":"0","summary":"证券之星消息，爱尔眼科(300015)01月23日在投资者关系平台上答复投资者关心的问题。投资者提问：该公司5年下跌，今年第六年！在Ai医疗窗口公司拥有广大的用户群体，公司如何让业绩再次增长？爱尔眼科回复：谢谢关注。公司致力于高质量长远发展，持续建设数智眼科，积极推进“1+8+N”的战略，增强诊疗网络能力，为全年龄段人群提供多层次的全眼科医疗服务，驱动业务不断增长。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012300019481.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0113","LU1820825898.SGD","LU0979878070.USD","BK0196","LU1242518857.USD","BK0200","LU1146622755.USD","LU1242518931.SGD","BK0012","BK0028","BK0236","BK0114","300015","BK0077","BK0188","BK0096"],"gpt_icon":0},{"id":"2605296274","title":"爱尔眼科实控人陈邦拟质押6200万股 累计质押2.7亿股","url":"https://stock-news.laohu8.com/highlight/detail?id=2605296274","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605296274?lang=zh_cn&edition=full","pubTime":"2026-01-23 14:15","pubTimestamp":1769148904,"startTime":"0","endTime":"0","summary":"中国经济网北京1月23日讯 爱尔眼科 昨日发布关于公司实际控制人进行股票质押式回购交易的公告。爱尔眼科近日接到公司实际控制人陈邦函告，获悉陈邦所直接持有公司的部分股份进行股票质押式回购交易。　　本次质押股数为6200万股，占其所持股份比例为4.29%，占公司总股本比例为0.66%，股份性质为流通股，质押起始日为2026年1月20日，到期日为2027年1月19日，质权人为国泰海通证券股份有限公司，用途为质押担保。","market":"sh","thumbnail":" http://caiji.3g.cnfol.com/colect/202601/23/20260123780078.png","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202601/23/20260123780078.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20260123/31966932.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0028","BK0077","BK0200","LU1820825898.SGD","LU1242518931.SGD","BK0188","BK0196","LU1146622755.USD","BK0114","LU1242518857.USD","BK0012","BK0096","BK0236","300015","LU0979878070.USD","BK0113"],"gpt_icon":0},{"id":"2605041577","title":"股市必读：爱尔眼科（300015）1月22日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2605041577","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605041577?lang=zh_cn&edition=full","pubTime":"2026-01-23 01:06","pubTimestamp":1769101562,"startTime":"0","endTime":"0","summary":"截至2026年1月22日收盘，爱尔眼科报收于11.18元，下跌0.18%，换手率0.7%，成交量55.77万手，成交额6.25亿元。公司公告汇总关于公司实际控制人进行股票质押式回购交易的公告爱尔眼科实际控制人陈邦于2026年1月20日将其持有的62,000,000股公司股份质押给国泰海通证券股份有限公司，用于股票质押式回购交易，质押期限至2027年1月19日。此次质押后，陈邦累计质押股份占其所持股份的18.71%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012300000567.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300015","LU1242518857.USD","BK0196","BK0200","LU1820825898.SGD","LU1146622755.USD","BK0028","BK0236","LU1242518931.SGD","BK0096","BK0114","LU0979878070.USD","BK0077","BK0113","BK0188","BK0012"],"gpt_icon":0},{"id":"2604137696","title":"股市必读：爱尔眼科（300015）1月19日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2604137696","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604137696?lang=zh_cn&edition=full","pubTime":"2026-01-20 01:00","pubTimestamp":1768842040,"startTime":"0","endTime":"0","summary":"截至2026年1月19日收盘，爱尔眼科报收于11.33元，下跌0.44%，换手率0.78%，成交量61.81万手，成交额7.01亿元。董秘最新回复投资者： 未来公司的盈利增长点在哪里？公司将加快业务创新，促进各学科全面发展，通过为全年龄段人群提供全眼科优质服务，推动诊疗量不断增长。当日关注点来自交易信息汇总：1月19日主力资金净流出2733.49万元，散户资金净流入3599.08万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012000000463.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","300015","LU1242518857.USD","BK0113","BK0114","LU0979878070.USD","BK0236","LU1820825898.SGD","LU1242518931.SGD","BK0188","BK0077","LU1146622755.USD","BK0196","BK0012","BK0096","BK0200"],"gpt_icon":0},{"id":"2604183671","title":"爱尔眼科：推动全年龄段全眼科服务发展","url":"https://stock-news.laohu8.com/highlight/detail?id=2604183671","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604183671?lang=zh_cn&edition=full","pubTime":"2026-01-19 15:15","pubTimestamp":1768806915,"startTime":"0","endTime":"0","summary":"证券之星消息，爱尔眼科01月19日在投资者关系平台上答复投资者关心的问题。工作、生活的手机化持续增加用眼时长和用眼强度，眼科服务需求实际在逐步扩大。公司将加快业务创新，促进各学科全面发展，通过为全年龄段人群提供全眼科优质服务，推动诊疗量不断增长。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011900014050.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0096","BK0113","BK0028","BK0188","LU0979878070.USD","LU1242518931.SGD","LU1820825898.SGD","LU1242518857.USD","BK0236","BK0077","BK0200","BK0196","LU1146622755.USD","300015","BK0114","BK0012"],"gpt_icon":0},{"id":"2603596525","title":"爱尔眼科：AI模拟优化手术方案提高术后效果","url":"https://stock-news.laohu8.com/highlight/detail?id=2603596525","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603596525?lang=zh_cn&edition=full","pubTime":"2026-01-16 16:33","pubTimestamp":1768552389,"startTime":"0","endTime":"0","summary":"证券之星消息，爱尔眼科01月16日在投资者关系平台上答复投资者关心的问题。请问贵司对于眼科方面有无引进AI辅助或应用于眼科的技术或者大模型？目前“全光塑”即是屈光手术的应用之一，实现个性化手术。另外，对于一些角膜不规则或异常切削的情况，以往主要依靠医生经验，现在可以通过人工模拟优化方案，提高术后效果。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011600024814.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0113","BK0188","LU0979878070.USD","LU1146622755.USD","BK0028","BK0196","LU1820825898.SGD","BK0200","BK0114","BK0012","BK0077","BK0236","300015","LU1242518857.USD","LU1242518931.SGD","BK0096"],"gpt_icon":0},{"id":"2603269536","title":"爱尔眼科：稳步推进“智慧医院”建设","url":"https://stock-news.laohu8.com/highlight/detail?id=2603269536","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603269536?lang=zh_cn&edition=full","pubTime":"2026-01-14 16:18","pubTimestamp":1768378716,"startTime":"0","endTime":"0","summary":"证券之星消息，爱尔眼科(300015)01月14日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好，你们有没有引入AI技术？还有马斯克脑机接口技术实践证明对眼睛视力有帮助，请问你们计划研究吗？爱尔眼科回复：谢谢您对公司的关注。公司稳步推进“智慧医院”建设，持续关注前沿交叉领域的新进展。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011400024550.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0196","LU1820825898.SGD","LU1242518931.SGD","BK0236","BK0077","BK0096","300015","BK0200","LU0979878070.USD","LU1146622755.USD","LU1242518857.USD","BK0028","BK0188","BK0012","BK0113","BK0114"],"gpt_icon":0},{"id":"2602359075","title":"爱尔眼科：2025年多家医院引进蔡司新一代机器人全飞秒设备","url":"https://stock-news.laohu8.com/highlight/detail?id=2602359075","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602359075?lang=zh_cn&edition=full","pubTime":"2026-01-12 17:18","pubTimestamp":1768209487,"startTime":"0","endTime":"0","summary":"证券之星消息，爱尔眼科01月12日在投资者关系平台上答复投资者关心的问题。现在好多酒店都用上机器人了爱尔眼科回复：谢谢关注！2025年，公司旗下多家医院引进蔡司新一代机器人全飞秒设备 VISUMAX800及全新微创手术 SMILEpro；长沙医学中心成功实施湖南省首例眼科手术机器人辅助视网膜下精准注射手术。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011200023472.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0077","BK0028","BK0114","BK0188","BK0113","LU1146622755.USD","BK0236","LU1242518857.USD","LU1820825898.SGD","300015","BK0196","LU0979878070.USD","BK0096","BK0200","LU1242518931.SGD"],"gpt_icon":0},{"id":"2602859795","title":"爱尔眼科完成《公司章程》备案","url":"https://stock-news.laohu8.com/highlight/detail?id=2602859795","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602859795?lang=zh_cn&edition=full","pubTime":"2026-01-12 16:42","pubTimestamp":1768207347,"startTime":"0","endTime":"0","summary":"中访网数据  爱尔眼科医院集团股份有限公司近日发布公告，宣布已完成《公司章程》的备案手续。此前，公司于2025年11月10日召开第六届董事会第四十四次会议，并于2025年11月27日召开2025年第三次临时股东大会，审议通过了关于修订《公司章程》并办理市场主体变更登记的议案。此次修订及备案工作的完成，标志着公司治理结构的相关调整已正式落地，符合相关监管规定。根据公告，修订后的《公司章程》已同步披露。作为创业板上市公司(证券代码：300015)，《公司章程》的更新与备案是公司规范运作、完善治理的重要步骤，有助于保障公司及全体股东的合法权益。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20260112/31934480.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0096","LU0979878070.USD","BK0200","BK0196","LU1242518857.USD","LU1820825898.SGD","BK0114","BK0113","300015","BK0188","LU1146622755.USD","BK0028","BK0077","BK0236","LU1242518931.SGD","BK0012"],"gpt_icon":0},{"id":"2602800592","title":"爱尔眼科：Deepseek用R1和V3.2，ChatGPT用V5.1和V5.2","url":"https://stock-news.laohu8.com/highlight/detail?id=2602800592","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602800592?lang=zh_cn&edition=full","pubTime":"2026-01-12 16:12","pubTimestamp":1768205536,"startTime":"0","endTime":"0","summary":"证券之星消息，爱尔眼科(300015)01月12日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好，贵公司接入训练的是Deepseek几代，+ChatGPT训练到几代了？爱尔眼科回复：谢谢您对公司的关注。Deepseek用的是R1和 V3.2，ChartGPT用的是V5.1和V5.2，既有采取RAG的方式，也有做微调训练的方式。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011200017090.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300015"],"gpt_icon":0},{"id":"2602557933","title":"股市必读：1月9日爱尔眼科发生1笔大宗交易 成交金额249.95万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2602557933","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602557933?lang=zh_cn&edition=full","pubTime":"2026-01-12 02:27","pubTimestamp":1768156030,"startTime":"0","endTime":"0","summary":"截至2026年1月9日收盘，爱尔眼科报收于11.42元，上涨0.97%，换手率0.78%，成交量62.39万手，成交额7.11亿元。当日关注点来自交易信息汇总：1月9日主力资金净流入732.23万元，显示主力对爱尔眼科的短期关注度提升。来自交易信息汇总：同日游资资金净流出1358.58万元，表明游资在当日选择离场。来自交易信息汇总：散户资金净流入626.35万元，反映出散户投资者情绪偏积极。大宗交易1月9日爱尔眼科发生1笔大宗交易，成交金额249.95万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011200000982.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0114","BK0236","LU1242518857.USD","BK0077","LU1820825898.SGD","BK0200","BK0188","BK0012","BK0113","300015","BK0096","LU1146622755.USD","LU0979878070.USD","LU1242518931.SGD","BK0028","BK0196"],"gpt_icon":0},{"id":"2602197763","title":"公募“圈地”指数基金，“一指多发”仍是头部游戏","url":"https://stock-news.laohu8.com/highlight/detail?id=2602197763","media":"券商中国","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602197763?lang=zh_cn&edition=full","pubTime":"2026-01-09 07:20","pubTimestamp":1767914400,"startTime":"0","endTime":"0","summary":"炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！　　持续落子之下，基金公司在指数基金上的“圈地”策略逐渐清晰。　　券商中国记者发现，在岁末年初的基金发行中，华泰柏瑞、汇添富、易方达等公募“一指多发”持续抢占市场份额。但这种长达数年乃至十年的策略布局，多见于头部公募，中小公募仍难以分到杯羹。　　即便是不发ETF的公募，中证A500布局同样“一指多发”。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/marketresearch/2026-01-09/doc-inhfsfzx6020676.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["515890","000905.SH","000688.SH","BK4550","510300","BK4588","159967","SINA","600621","000300.SH","06030","399001","CIIHY","000166","510880","512510","300015","600030","06806","399006","BK4585","512880"],"gpt_icon":0},{"id":"2602919863","title":"股市必读：爱尔眼科（300015）1月8日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2602919863","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602919863?lang=zh_cn&edition=full","pubTime":"2026-01-09 01:20","pubTimestamp":1767892819,"startTime":"0","endTime":"0","summary":"截至2026年1月8日收盘，爱尔眼科报收于11.31元，上涨0.44%，换手率0.63%，成交量50.11万手，成交额5.66亿元。董秘最新回复投资者： 贵公司开发的数字人运行的怎么样，大面积运用了吗？爱尔数字人“爱科” 已在部分大医院试运行，提供眼健康科普、医院信息咨询、诊疗及用药注意事项等功能，并持续升级逐步推广，助力眼科医院智能化。当日关注点来自交易信息汇总：1月8日主力资金净流出1659.82万元，散户资金净流入1318.68万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010900000925.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU0979878070.USD","BK0077","BK0236","LU1242518857.USD","BK0114","BK0012","LU1242518931.SGD","BK0196","LU1820825898.SGD","BK0096","BK0113","300015","BK0200","BK0188","BK0028","LU1146622755.USD"],"gpt_icon":0},{"id":"2601635478","title":"爱尔眼科：数字人“爱科”已在部分大医院试运行","url":"https://stock-news.laohu8.com/highlight/detail?id=2601635478","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601635478?lang=zh_cn&edition=full","pubTime":"2026-01-08 17:00","pubTimestamp":1767862839,"startTime":"0","endTime":"0","summary":"证券之星消息，爱尔眼科(300015)01月08日在投资者关系平台上答复投资者关心的问题。投资者提问：贵公司开发的数字人运行的怎么样，大面积运用了吗？爱尔眼科回复：谢谢您对公司的关注。爱尔数字人“爱科（Eyecho）” 已在部分大医院试运行，提供眼健康科普、医院信息咨询、诊疗及用药注意事项等功能，并持续升级逐步推广，助力眼科医院智能化。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010800026566.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0113","BK0188","LU0979878070.USD","LU1146622755.USD","BK0028","BK0196","LU1820825898.SGD","BK0200","BK0114","BK0012","BK0077","BK0236","300015","LU1242518857.USD","LU1242518931.SGD","BK0096"],"gpt_icon":0},{"id":"2601766378","title":"爱尔眼科：小青葵系列产品已实现量产","url":"https://stock-news.laohu8.com/highlight/detail?id=2601766378","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601766378?lang=zh_cn&edition=full","pubTime":"2026-01-07 17:21","pubTimestamp":1767777668,"startTime":"0","endTime":"0","summary":"证券之星消息，爱尔眼科(300015)01月07日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好，公司自主研发的（小青葵）系列产品量产了吗？爱尔眼科回复：谢谢您对公司的关注。“小青葵”系列产品已实现量产，具有良好的近视防控效果。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010700026478.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300015","BK0188","BK0077","BK0028","BK0114","LU1146622755.USD","LU1242518857.USD","LU1820825898.SGD","LU1242518931.SGD","BK0196","BK0200","BK0096","BK0236","LU0979878070.USD","BK0113","BK0012"],"gpt_icon":0},{"id":"2601187268","title":"爱尔眼科（300015）披露2025年中期分红派息实施公告，1月6日股价上涨1.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601187268","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601187268?lang=zh_cn&edition=full","pubTime":"2026-01-06 22:08","pubTimestamp":1767708507,"startTime":"0","endTime":"0","summary":"截至2026年1月6日收盘，爱尔眼科报收于11.4元，较前一交易日上涨1.97%，最新总市值为1063.1亿元。该股当日开盘11.19元，最高11.48元，最低11.19元，成交额达10.57亿元，换手率为1.17%。公司近日发布公告称，将实施2025年中期分红派息方案。本次分红以公司总股本9,325,396,670股扣除回购股份31,363,178股后的9,294,033,492股为基数，向全体股东每10股派0.8元现金（含税），共计派发743,522,679.36元。现金红利由中国证券登记结算有限责任公司深圳分公司代派，部分股东由公司自行派发。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010600042251.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","LU0979878070.USD","LU1146622755.USD","LU1242518857.USD","BK0188","BK0196","BK0200","BK0077","BK0113","BK0114","LU1242518931.SGD","LU1820825898.SGD","BK0028","BK0096","BK0236","300015"],"gpt_icon":0},{"id":"2601898179","title":"爱尔眼科：子公司更名系为更好满足发展需要","url":"https://stock-news.laohu8.com/highlight/detail?id=2601898179","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601898179?lang=zh_cn&edition=full","pubTime":"2026-01-06 17:27","pubTimestamp":1767691634,"startTime":"0","endTime":"0","summary":"证券之星消息，爱尔眼科(300015)01月06日在投资者关系平台上答复投资者关心的问题。投资者提问：请问2023年为什么要将2022年合并而来的宜昌西陵爱尔眼科医院有限公司更名为宜昌爱尔东山眼科医院有限公司，且未在年报中做说明，并且同年新设同名子公司“宜昌西陵爱尔眼科医院有限公司”，导致“宜昌西陵爱尔”这一标识同时出现在新设主体与商誉披露中爱尔眼科回复：谢谢关注。子公司更名是为了更好地满足发展需要，相关操作及信息披露符合法规要求。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010600028916.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1242518857.USD","LU1146622755.USD","LU0979878070.USD","LU1820825898.SGD","BK0077","BK0188","BK0096","BK0114","BK0113","300015","BK0196","BK0012","BK0028","LU1242518931.SGD","BK0200","BK0236"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1769932442441,"stockEarnings":[{"period":"1week","weight":-0.0204},{"period":"1month","weight":0.015},{"period":"3month","weight":-0.0902},{"period":"6month","weight":-0.1333},{"period":"1year","weight":-0.0844},{"period":"ytd","weight":0.015}],"compareEarnings":[{"period":"1week","weight":-0.0044},{"period":"1month","weight":0.0376},{"period":"3month","weight":0.0413},{"period":"6month","weight":0.1567},{"period":"1year","weight":0.2668},{"period":"ytd","weight":0.0376}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"爱尔眼科医院集团股份有限公司","boardCode":"AI0083","boardName":"卫生","stockholders":"344788人(较上一季度增加0.27%)","perCapita":"23073股","listingDate":"2009-10-30","address":"湖南省长沙市天心区芙蓉南路一段188号爱尔大厦","registeredCapital":"932539万元","survey":"　　爱尔眼科医院集团股份有限公司的主营业务是各类眼科疾病诊疗、手术服务与医学验光配镜服务。公司的主要产品是屈光项目、白内障项目、眼前段项目、眼后段项目、视光服务项目。","listedPrice":28},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"爱尔眼科(300015)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供爱尔眼科(300015)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"爱尔眼科,300015,爱尔眼科股票,爱尔眼科股票老虎,爱尔眼科股票老虎国际,爱尔眼科行情,爱尔眼科股票行情,爱尔眼科股价,爱尔眼科股市,爱尔眼科股票价格,爱尔眼科股票交易,爱尔眼科股票购买,爱尔眼科股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"爱尔眼科(300015)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供爱尔眼科(300015)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}